IGH/BCL2:T(14;18), FOLLICULAR LYMPHOMA / HEPARIN BLOOD

image not found

NABL Cap Accredited     
The IGH/BCL2: t(14;18) test for Follicular Lymphoma at Metropolis Healthcare detects the chromosomal translocation associated with this type of lymphoma. It is performed on heparinized blood and helps identify the rearrangement between the IGH gene on chromosome 14 and the BCL2 gene on chromosome 18. Metropolis Healthcare uses advanced molecular diagnostic techniques to support accurate diagnosis and monitoring. This test is valuable for confirming suspected cases of follicular lymphoma and guiding treatment planning. Early detection enables better clinical outcomes and personalized care

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 4,770.00

Sample Type: HEPARIN BLOOD

Fasting Not Required


Notes: I0317

Frequently Asked Questions (FAQ's):

What does this test include?
This test at Metropolis Healthcare detects the IGH/BCL2 t(14;18) chromosomal translocation linked to follicular lymphoma using heparinized blood.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses highly sensitive molecular techniques such as PCR or FISH to identify the gene rearrangement accurately.

Who should take this test?
Patients with suspected or confirmed follicular lymphoma, abnormal lymph node enlargement, or persistent blood abnormalities may be advised to undergo testing at Metropolis Healthcare.

Why is this test important in follicular lymphoma?
The test helps confirm diagnosis, determine disease characteristics, and support treatment planning based on molecular findings provided by Metropolis Healthcare.

Do I need any preparation before the test at Metropolis Healthcare?
No special preparation or fasting is required; a blood sample collected in a heparin tube is used for analysis.

How long does it take to receive results?
Metropolis Healthcare generally delivers results within several working days, depending on the complexity of molecular analysis.

How are the results used by clinicians?
Results from Metropolis Healthcare help oncologists monitor disease progression, evaluate prognosis, and assess treatment response.

Is this test safe?
Yes, the test involves a routine blood draw performed safely by trained phlebotomists at Metropolis Healthcare

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab